Jonathan Sadeh, MD, MSc: Afimetoran Improves Disease Activity, Severity in Lupus

Results provide the first clinical evidence to suggest that afimetoran may offer a benefit to patients with cutaneous lupus erythematosus.

Related Keywords

,Jonathan Sadeh ,Bristol Myers Squibb ,American College Of Rheumatology ,Global Program Leaders ,Severity Index Activity ,American College ,